Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT00606398 | Combined Resection of Colorectal Metastases(CRC) | completed | Phase 2 | 56 | University Health Network, TorontoOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00943449 |
| 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma(Shelter) |
| completed |
| Phase 2 |
| 57 |
| 4SC AGINDUSTRY |
| 2 |
| Jan 16, 2014 |
| clinicaltrials |
| NCT00949182 | Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 20 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00281736 | Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer | completed | Phase 2 | 60 | Roswell Park Cancer InstituteOTHER | 1 | Jan 3, 2014 | clinicaltrials |
| NCT00297141 | Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma | completed | Phase 2 | 60 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00975897 | Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | completed | Phase 2 / Phase 3 | 3,240 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 43 | AmgenINDUSTRY | 0 | Dec 12, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00005874 | Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00025441 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | completed | Phase 2 | — | Societe Internationale d'Oncologie PediatriqueOTHER | 3 | Dec 4, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT00215982 | Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Nov 25, 2013 | clinicaltrials |
| NCT00470184 | Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | completed | Phase 2 | 41 | Roswell Park Cancer InstituteOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00986518 | T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study(STARTREK) | completed | Phase 1 / Phase 2 | 5 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01388790 | Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer | completed | Phase 2 | 40 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00003591 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | completed | Phase 2 | 122 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 13, 2013 | clinicaltrials |
| NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | completed | Phase 2 | 50 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00767377 | Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | completed | Phase 2 | 163 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | completed | Phase 2 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | completed | Phase 2 | 46 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00052689 | Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00077545 | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | completed | Phase 2 | 30 | Chung-Ang UniversityOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01945879 | Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 19 | CONKO-StudiengruppeOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00475293 | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC | completed | Phase 2 | 85 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Sep 13, 2013 | clinicaltrials |
| NCT01204177 | Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) | completed | Phase 2 | 70 | BayerINDUSTRY | 4 | Sep 6, 2013 | clinicaltrials |
| NCT00002951 | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | completed | Phase 2 | 53 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00003192 | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | completed | Phase 2 | 15 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00022477 | BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 24 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00026299 | Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | 14 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00053222 | Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | completed | Phase 2 | 13 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01934829 | Urea Cream Treatment Sorafenib-Associated HSFR in HCC | completed | Phase 2 | 871 | Chinese Anti-Cancer AssociationOTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT01086618 | Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 / Phase 3 | 500 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00632268 | Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00660140 | Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | completed | Phase 2 | 49 | Washington University School of MedicineOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT00335543 | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | completed | Phase 2 | 254 | Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen KrebsgesellschaftOTHER | 3 | Aug 12, 2013 | clinicaltrials |
| NCT00462852 | Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 120 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00064051 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 3 | Aug 2, 2013 | clinicaltrials |
| NCT00971841 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 1 | Bristol-Myers SquibbINDUSTRY | 0 | Jul 26, 2013 | clinicaltrials |
| NCT00002655 | Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases | completed | Phase 2 | — | University of Colorado, DenverOTHER | 1 | Jul 22, 2013 | clinicaltrials |
| NCT00084383 | Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | completed | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 22, 2013 | clinicaltrials |
| NCT00009880 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | completed | Phase 2 | 48 | Center for Molecular MedicineOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00054249 | T900607 in Treating Patients With Gastroesophageal Junction Cancer | completed | Phase 2 | — | University Hospitals Seidman Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00054262 | T900607 in Treating Patients With Unresectable Liver Cancer | completed | Phase 2 | — | University Hospitals Seidman Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00058487 | Epirubicin and Thalidomide in Treating Patients With Liver Cancer | completed | Phase 2 | 12 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Feb 6, 2014source: clinicaltrials